April 24 (Reuters) - U.S. biopharmaceutical company Hyperion Therapeutics said on Thursday it agreed to buy Israel's Andromeda Biotech, a developer of a new diabetes drug, in a deal that could be ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Aug. 7, 2006--As more customers than ever embrace solutions from Hyperion (Nasdaq:HYSL), the global leader in Business Performance Management (BPM) software, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback